Local Ablation in Pancreatic Cancer: IRE Versus SBRT

In the first part of this video series, Rebekah R. White, MD, FACS, and Zachary T. Berman, MD, both of the University of California, San Diego, explain the lack of consensus for treatment options for locally advanced pancreatic cancer beyond systemic chemotherapy and the rationale for investigation into irreversible electroporation (IRE).

Together, they elucidate the insights gained from the CROSSFIRE trial comparing IRE with stereotactic body radiotherapy in this space.

View their further comments on Ongoing Trials and Investigative Directions.